All In Biotech

Drug Trial Radar · NCT06477237

Study of Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of HB0017 Injection in Patients With Moderate to Severe Plaque Psoriasis

Last checked: Nov 19, 2026Latest source record: Oct 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 408 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

408

Actual

Start

Mar 29, 2024

Primary completion

Nov 15, 2024

Study completion Oct 31, 2025

Sponsor

Lead sponsor
Huabo Biopharm Co., Ltd.Industry
Sponsor type
Industry
First posted
Jun 27, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicenter, randomized, double-blind, placebo-controlled, phase III clinical study which is designed to determine the efficacy, safety, immunogenicity and pharmacokinetics, and pharmacodynamics of HB0017 Injection in the treatment of moderate to severe plaque psoriasis in adults.

Conditions

  • Psoriasis

Interventions

  • HB0017 Q4WBiological

    HB0017 at W0,1,2,4,8+HB0017Q4W

  • HB0017 Q8WBiological

    HB0017 at W0,1,2,4,8+HB0017Q8W

  • placeboBiological

    placebo at W0,1,2,4,8+HB0017Q4W

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of subjects achieving PASI 75 response at Week 12Time frame: Week 12
  2. Proportion of subjects achieving sPGA 0/1 response at Week 12Time frame: Week 12

Locations

44 sites in 1 country. Site status is shown where the registry gives one.

  • Beijing Friendship Hospital

    Beijing, China

  • China-Japan Friendship hospital

    Beijing, China

  • Peking University People's Hospital

    Beijing, China

  • The First Affiliated Hospital of Bengbu Medical College

    Bengbu, China

  • Jilin University Second Hospital

    Changchun, China

  • The first hospital of Jilin University

    Changchun, China

  • Xiangya Hospital of Central South University

    Changsha, China

  • Affiliated Hospital of Chengde Medical University

    Chengde, China

  • Sichuan Provincial People's Hospital

    Chengdu, China

  • West China Hospital of Sichuan University

    Chengdu, China

  • Chongqing Traditional Chinese Medicine Hospital

    Chongqing, China

  • Dongguan People's Hospital

    Dongguan, China

  • The First Affiliated Hospital of Fujian Medical University

    Fuzhou, China

  • Dermatology Hospital of Southern Medical University

    Guangzhou, China

  • Guangdong Provincial People's Hospital

    Guangzhou, China

  • Hangzhou First People's Hospital

    Hangzhou, China

  • Hangzhou Third People's Hospital

    Hangzhou, China

  • The First Affiliated Hospital of Zhejiang University School of Medicine

    Hangzhou, China

  • The Second Affiliated Hospital of Harbin Medical University

    Harbin, China

  • The Second Affiliated Hospital of Anhui Medical University

    Hefei, China

  • Jiaxing First Hospital

    Jiaxing, China

  • Shandong Dermatology Hospital

    Jinan, China

  • Jining First People's Hospital

    Jining, China

  • The First Affiliated Hospital of Kunming Medical University

    Kunming, China

  • The Second Affiliated Hospital of Kunming Medical University

    Kunming, China

  • The Second Affiliated Hospital of Henan University of Science and Technology

    Luoyang, China

  • Dermatology Hospital of Jiangxi Province

    Nanchang, China

  • The Second Affiliated Hospital of Nanchang University

    Nanchang, China

  • Jiangsu University Affiliated Hospital

    Nanjing, China

  • Ningbo Second Hospital

    Ningbo, China

  • Shanghai Dermatology Hospital

    Shanghai, China

  • People's Hospital of Liaoning Province

    Shenyang, China

  • Shenzhen People's Hospital

    Shenzhen, China

  • Shiyan People's Hospital

    Shiyan, China

  • The Second Hospital of Shanxi Medical University

    Taiyuan, China

  • Wenzhou Medical University Affiliated First Hospital

    Wenzhou, China

  • Wuhan University People's Hospital

    Wuhan, China

  • The First Affiliated Hospital of Wannan Medical College

    Wuhu, China

  • Wuxi Second People's Hospital

    Wuxi, China

  • The Second Affiliated Hospital of Xi'an Jiaotong University

    Xi'an, China

Showing 40 of 44 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.